Friday, July 25, 2014 12:26 AM
(NYSE: LUX) reported accelerated net sales growth in the second quarter ending June 30, 2014 to €2,060 million, up 7 percent at constant exchange rates when compared to the €2,018 million generated during the same period of 2013, according to the company’s financial results released yesterday.
Wednesday, July 23, 2014 12:26 AM
(NYSE: AGN) reported $1,827.3 million total product net sales for the quarter ended June 30, 2014, a 15.9 percent compared to total product net sales in the second quarter of 2013.
Monday, July 21, 2014 12:36 AM
WILMINGTON, Del.—The Chapter 11 bankruptcy proceedings for MacKeyser
Holdings, LLC and its subsidiaries, which include American Optical
Services (AOS) and a number of other optical businesses the company had
acquired prior to its bankruptcy, proceeded last week with the company’s
second court appearance on July 16.
Monday, July 21, 2014 12:24 AM
(NYSE: AGN) will host a conference call to discuss the company’s second
quarter 2014 results today beginning at 7:30 a.m. Pacific Time (10:30 am
Eastern Time) with David Pyott, chairman and CEO, and Jeff Edwards,
executive vice president, finance and business development and chief
Friday, July 18, 2014 12:24 AM
LONDON—Retinal imaging company,
OPTS) announced yesterday that its revenues for the company’s third
quarter (the three-month period ending June 30, 2014) of the company’s
2014 fiscal year were $42 million, 5 percent higher than the $40.1
million generated during the comparable period last year.
Wednesday, July 16, 2014 12:27 AM
(NYSE: AGN) has filed an investor presentation with the Securities and
Exchange Commission that raises further concerns about what it
characterizes as “potential business risks and issues” related to a
proposed purchase by
Valeant Pharmaceuticals International
Wednesday, July 16, 2014 12:14 AM
NEW BRUNSWICK, N.J.—U.S. sales for the vision care division of
Johnson & Johnson
(NYSE: JNJ) remained flat at $262 million for the second quarter of 2014
when compared with an equal amount of sales for the same period for
2013, according to the 2014 second quarter financial results released
yesterday by the company.
Monday, June 30, 2014 12:26 AM
IRVINE, Calif.—Reuters reported Pershing Square Capital Management, led by activist investor William Ackman, and
agreed that calling a special meeting in an effort to elect new board
members will not trigger Allergan's so-called "poison pill" measure,
settling a lawsuit, the companies said on Friday.
Friday, June 27, 2014 12:26 AM
IRVINE, Calif.—Reuters reported Wednesday that hedge fund Paulson & Co has amassed more than 6 million shares of
(NYSE: AGN) stock and supports a deal between Allergan and
(NYSE/TSX: VRX), people familiar with the matter told Reuters.
Friday, June 20, 2014 12:30 AM
Valeant Pharmaceuticals International
(NYSE: VRX), based here, stepped up its bid to acquire Botox-maker
(NYSE: AGN) by announcing Wednesday that it is taking its latest proposal directly to Allergan stockholders.
Wednesday, June 18, 2014 12:26 AM
MADISON, Wis.—Online eyewear and accessories retailer,
received a $250,000 loan from the Wisconsin Economic Development Corporation (WEDC).
Wednesday, June 11, 2014 12:29 AM
(NYSE:AGN) announced yesterday that its board of directors, after
consulting with its independent financial and legal advisors, has
unanimously determined that the revised unsolicited proposal dated May
30, 2014 by Pershing Square Capital Management, L.P. and Valeant
Pharmaceuticals International, Inc. “substantially undervalues the
company, creates significant risks and uncertainties for the
stockholders of Allergan, and is not in the best interests of the
company and its stockholders.”
Wednesday, June 11, 2014 12:26 AM
Cooper Companies, Inc.
(NYSE:COO) announced financial results for the fiscal second quarter ended April 30, 2014.
Friday, June 06, 2014 12:23 AM
(OTC:QB: VUZI) has entered into a definitive agreement with
institutional investors for the sale of $3 million in aggregate
principal amount of 5 percent Senior Secured Convertible Notes due June